Abstract:Introduction. Kaposi's sarcoma (KS) usually manifests as a cutaneous disease but GI manifestation is often rare. It is associated with human herpes virus-8 (HHV-8) and seen in immunocompromised patients. In the USA, use of highly active antiretroviral therapy (HAART) has drastically reduced incidence of KS in HIV patients. Case Presentation. A 65-year-old male with human immunodeficiency virus (HIV) was admitted to the intensive care unit (ICU) with cardiopulmonary arrest secondary to hyperkalemia of 7.5 meq/L… Show more
“…In the last 10 years, only 3 case reports have described patients with gastrointestinal lesions in the absence of cutaneous manifestations, as in our patient [ 6 , 9 , 10 ]. One case report by Daar et al in 2017 showed a similar presentation in a 65-year-old man with upper gastrointestinal lesions in the absence of cutaneous lesions, following a sharp drop in the hemoglobin level and findings of stool occult blood on admission.…”
Section: Discussionmentioning
confidence: 68%
“…AIDS-Kaposi sarcoma presenting exclusively with gastrointestinal lesions is seldom described in the literature. It is reported that 90% of Kaposi sarcoma presentations involve cutaneous lesions [ 6 ], with dark, violaceous plaques and nodules on the epidermis and mucosa. Few case reports have shown Kaposi sarcoma lesions in the setting of gastrointestinal bleeding; however, in most of these case reports, gastrointestinal lesions were also accompanied by dark violaceous cutaneous lesions on the face, trunk, or extremities [ 7 , 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…AIDS-associated Kaposi sarcoma has no preferred location, it is widely scattered, and involvement of the lymph nodes and intestine usually occurs early [ 6 ]. Visceral involvement of Kaposi sarcoma without cutaneous lesions is rare in patients with AIDS/HIV.…”
Patient: Male, 35-year-old
Final Diagnosis: Gastrointestinal Kaposi sarcoma
Symptoms: Abdominal pain • fatigue • melena
Clinical Procedure: —
Specialty: Infectious Diseases • General and Internal Medicine • Oncology
Objective:
Unusual clinical course
Background:
Kaposi sarcoma is a malignancy of the vascular endothelium. It is associated with human herpesvirus 8 (HHV-8) infection, typically found with HIV/AIDS. It is rarely seen presenting as visceral involvement without any cutaneous lesions. Few case reports have described this.
Case Report:
We report a case of visceral Kaposi sarcoma (specifically, gastrointestinal lesions) without any cutaneous lesions in a 35-year-old man with HIV/AIDS who presented with abdominal pain, fatigue, and melena of a 15-day duration. Physical examination revealed tachycardia and hypertension, with a negative orthostatic sign. There were no visible signs of bleeding or cutaneous lesions, no abdominal pain, and a digital rectal examination was negative. Laboratory test results were significant for severe microcytic anemia, with hemoglobin level of 3.3 g/dL, decreased ferritin and iron levels, high red cell distribution width, and reticulocyte index lower than appropriate for anemia level. The absolute CD4 count was 33/uL, and the viral load was 56 895 copies/mL. Hemoglobin was optimized with packed red cells prior to endoscopy, and Pneumocystis jirovecii pneumonia prophylaxis was started. Esophagogastroduodenoscopy and colonoscopy revealed small and large bowel hemorrhagic stel-late and annular lesions of varying sizes. Pathology reports from biopsy of the lesions seen in the procedure reported Kaposi sarcoma positive for HHV-8. He underwent chemotherapy with doxorubicin and showed clinical and laboratory improvement after treatment.
Conclusions:
Kaposi sarcoma should be considered and investigated in patients with HIV/AIDS who are not on highly active antiretroviral therapy and present with gastrointestinal bleeding as an initial symptom, without any cutaneous lesions.
“…In the last 10 years, only 3 case reports have described patients with gastrointestinal lesions in the absence of cutaneous manifestations, as in our patient [ 6 , 9 , 10 ]. One case report by Daar et al in 2017 showed a similar presentation in a 65-year-old man with upper gastrointestinal lesions in the absence of cutaneous lesions, following a sharp drop in the hemoglobin level and findings of stool occult blood on admission.…”
Section: Discussionmentioning
confidence: 68%
“…AIDS-Kaposi sarcoma presenting exclusively with gastrointestinal lesions is seldom described in the literature. It is reported that 90% of Kaposi sarcoma presentations involve cutaneous lesions [ 6 ], with dark, violaceous plaques and nodules on the epidermis and mucosa. Few case reports have shown Kaposi sarcoma lesions in the setting of gastrointestinal bleeding; however, in most of these case reports, gastrointestinal lesions were also accompanied by dark violaceous cutaneous lesions on the face, trunk, or extremities [ 7 , 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…AIDS-associated Kaposi sarcoma has no preferred location, it is widely scattered, and involvement of the lymph nodes and intestine usually occurs early [ 6 ]. Visceral involvement of Kaposi sarcoma without cutaneous lesions is rare in patients with AIDS/HIV.…”
Patient: Male, 35-year-old
Final Diagnosis: Gastrointestinal Kaposi sarcoma
Symptoms: Abdominal pain • fatigue • melena
Clinical Procedure: —
Specialty: Infectious Diseases • General and Internal Medicine • Oncology
Objective:
Unusual clinical course
Background:
Kaposi sarcoma is a malignancy of the vascular endothelium. It is associated with human herpesvirus 8 (HHV-8) infection, typically found with HIV/AIDS. It is rarely seen presenting as visceral involvement without any cutaneous lesions. Few case reports have described this.
Case Report:
We report a case of visceral Kaposi sarcoma (specifically, gastrointestinal lesions) without any cutaneous lesions in a 35-year-old man with HIV/AIDS who presented with abdominal pain, fatigue, and melena of a 15-day duration. Physical examination revealed tachycardia and hypertension, with a negative orthostatic sign. There were no visible signs of bleeding or cutaneous lesions, no abdominal pain, and a digital rectal examination was negative. Laboratory test results were significant for severe microcytic anemia, with hemoglobin level of 3.3 g/dL, decreased ferritin and iron levels, high red cell distribution width, and reticulocyte index lower than appropriate for anemia level. The absolute CD4 count was 33/uL, and the viral load was 56 895 copies/mL. Hemoglobin was optimized with packed red cells prior to endoscopy, and Pneumocystis jirovecii pneumonia prophylaxis was started. Esophagogastroduodenoscopy and colonoscopy revealed small and large bowel hemorrhagic stel-late and annular lesions of varying sizes. Pathology reports from biopsy of the lesions seen in the procedure reported Kaposi sarcoma positive for HHV-8. He underwent chemotherapy with doxorubicin and showed clinical and laboratory improvement after treatment.
Conclusions:
Kaposi sarcoma should be considered and investigated in patients with HIV/AIDS who are not on highly active antiretroviral therapy and present with gastrointestinal bleeding as an initial symptom, without any cutaneous lesions.
“…Kaposi's sarcoma is rarely found in the esophagus, and presents as dysphagia rather than odynophagia [ 5 ]. It appears as submucosal ulcerations or as linitis plastica in the stomach [ 6 ]. While Kaposi’s sarcoma lesions in the latter parts of the upper GI tract are generally asymptomatic, it has been reported to cause acute hemorrhage [ 6 , 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…It appears as submucosal ulcerations or as linitis plastica in the stomach [ 6 ]. While Kaposi’s sarcoma lesions in the latter parts of the upper GI tract are generally asymptomatic, it has been reported to cause acute hemorrhage [ 6 , 7 ]. Our study did not document any cases of CMV/HSV infection or cases of Kaposi’s sarcoma or lymphoma, likely due to a relatively small sample size and higher CD4 count than that is usually found in patients with these disease entities.…”
BackgroundEndoscopic evaluation with biopsies are instrumental in the diagnosis and management of gastrointestinal (GI) disorders in the setting of human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), especially in the era of highly active antiretroviral therapy (HAART).MethodsA retrospective chart review of 304 HIV-positive and 199 HIV-negative patients who had undergone upper and/or lower endoscopy in an urban community hospital from the years 2012 - 2017 was performed. Inclusion criteria included men and women between the ages of 45 to 75 years, which had undergone colonoscopies between within 2012 - 2017 and had tested positive for HIV. They were selected from that population if they had complete charts that included information regarding symptoms, viral load, cluster of differentiation 4 (CD4) count, prescribed HAART medication, findings from the upper and lower colonoscopy both from the gastroenterologist’s report and pathologist’s report. Only then would they be added to the pool of final selection that we could compute data from and draw conclusions.ResultsAmong HIV patients, those with less than 200 CD4 cells/µL counts had lower rates of diverticulosis and hemorrhoids, as compared with those with greater than 200 cells/µL counts. Other gross and histological findings (from either upper or lower endoscopy) were not statistically different between these two groups. In HIV-positive patients, gastritis, Helicobacter pylori (HP) infection, and esophagitis were significantly less common, while Candida esophagitis was more common. Among HIV patients taking different HAART regimens, the prevalence of peptic ulcers was significantly higher in those taking IIs than that in those who were not.ConclusionsPhysicians should consider the possibility that the GI symptoms in HIV-infected patients on HAART may be due to an opportunistic infection, even when the CD4 count is more than 200 cells/µL and the viral load is low.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.